顶部logo
顶部logo
more_1

home

ホーム > レポート一覧 > グローバルB型肝炎抗ウイルス薬市場規模、主要企業シェア、ランキング分析レポート【2026年版】

グローバルB型肝炎抗ウイルス薬市場規模、主要企業シェア、ランキング分析レポート【2026年版】

Hepatitis B Antiviral Drugs - Global Top Players Market Share and Ranking 2026
  • レポートID：
    224005
  • 発表時期：
    2026-03-03
  • レポート形式：
    PDF
  • 産業カテゴリー：
    薬品及びサプリメント
  • レポート言語：
    英語、日本語
  • ページ数：
    103
  • 発行会社（調査会社）：
    YHResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.40円。

※米ドル表示価格+10％消費税。

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本報告書は、世界のB型肝炎抗ウイルス薬市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点からB型肝炎抗ウイルス薬市場を分析し、需要構造と成長特性を明確化します。
B型肝炎抗ウイルス薬市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、B型肝炎抗ウイルス薬に関する的確な意思決定を行うための実践的なインサイトを提供します。
 主要B型肝炎抗ウイルス薬市場の統計
2025年世界市場規模：百万米ドル
2026年世界市場規模：百万米ドル
2032年予測市場規模：百万米ドル
2026–2032年予測期間CAGR：
本レポートはB型肝炎抗ウイルス薬市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
B型肝炎抗ウイルス薬市場の主要企業には以下が含まれます：
GSK
Bristol Myers Squibb
Gilead Sciences
Novartis
Roche
Merck
Johnson & Johnson
Dawnrays Pharmaceutical
Hansoh Pharmaceutical
Chia Tai-Tianqing Pharmaceutical
Qilu pharmaceutical
Fujian Cosunter Pharma
Xiamen Amoytop Biotech
YaoPharma
Kelun Pharmaceutical 

製品別
Nucleos(t)ide Analogues
Interferons 

アプリケーション別
Hospital
Clinic
Others 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他

レポート構成（章別概要）
第1章｜市場概要と成長展望
B型肝炎抗ウイルス薬市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
B型肝炎抗ウイルス薬市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別にB型肝炎抗ウイルス薬市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別にB型肝炎抗ウイルス薬市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、B型肝炎抗ウイルス薬市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、B型肝炎抗ウイルス薬市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
B型肝炎抗ウイルス薬市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
 B型肝炎抗ウイルス薬市場の全体像と成長見通し
B型肝炎抗ウイルス薬市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境がB型肝炎抗ウイルス薬市場に与える影響を分析いたします
 市場環境の構成要素とマクロトレンド
B型肝炎抗ウイルス薬産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
 競争構造と主要企業の動向分析
B型肝炎抗ウイルス薬市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
 競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点からB型肝炎抗ウイルス薬市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
 成長要因・課題・リスクの分析
B型肝炎抗ウイルス薬市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
 将来トレンドと市場展望
B型肝炎抗ウイルス薬市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
title

Description

According to YH Research, the global market for Hepatitis B Antiviral Drugs should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of %for the period of 2026-2032.

By country, Japan accounted for percent of the global market last year and Japan’s market share increased from percent to percent. Japan Hepatitis B Antiviral Drugs market should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of % for the period of 2026-2032. The United States Hepatitis B Antiviral Drugs market should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of % for the period of 2026-2032.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.

This report studies and analyses global Hepatitis B Antiviral Drugs status and future trends, to help determine the Hepatitis B Antiviral Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Hepatitis B Antiviral Drugs, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Hepatitis B Antiviral Drugs market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Hepatitis B Antiviral Drugs by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Hepatitis B Antiviral Drugs by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Hepatitis B Antiviral Drugs key consuming regions, consumption value and demand structure
(5) Hepatitis B Antiviral Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    GSK
    Bristol Myers Squibb
    Gilead Sciences
    Novartis
    Roche
    Merck
    Johnson & Johnson
    Dawnrays Pharmaceutical
    Hansoh Pharmaceutical
    Chia Tai-Tianqing Pharmaceutical
    Qilu pharmaceutical
    Fujian Cosunter Pharma
    Xiamen Amoytop Biotech
    YaoPharma
    Kelun Pharmaceutical

Market segment by Type, covers
    Nucleos(t)ide Analogues
    Interferons

Market segment by Application, can be divided into
    Hospital
    Clinic
    Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Hepatitis B Antiviral Drugs product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Hepatitis B Antiviral Drugs market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Hepatitis B Antiviral Drugs market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Hepatitis B Antiviral Drugs industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions
title

Table of Contents

1 Market Overview
    1.1 Hepatitis B Antiviral Drugs Definition
    1.2 Global Hepatitis B Antiviral Drugs Market Size and Forecast
    1.3 Japan Hepatitis B Antiviral Drugs Market Size and Forecast
    1.4 Share of Japan Hepatitis B Antiviral Drugs Market with Respect to the Global Market
    1.5 Hepatitis B Antiviral Drugs Market Size: Japan VS Global Growth Rate, 2021-2032
    1.6 Hepatitis B Antiviral Drugs Market Dynamics
        1.6.1 Hepatitis B Antiviral Drugs Market Drivers
        1.6.2 Hepatitis B Antiviral Drugs Market Restraints
        1.6.3 Hepatitis B Antiviral Drugs Industry Trends
        1.6.4 Hepatitis B Antiviral Drugs Industry Policy
2 Global Leading Players and Market Share
    2.1 By Revenue of Hepatitis B Antiviral Drugs, Global Market Share by Company, 2021-2026
    2.2 Global Hepatitis B Antiviral Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.3 Global Hepatitis B Antiviral Drugs Concentration Ratio
    2.4 Global Hepatitis B Antiviral Drugs Mergers & Acquisitions, Expansion Plans
    2.5 Global Hepatitis B Antiviral Drugs Major Companies Product Type
    2.6 Head Office and Area Served of Key Players
3 Japan Leading Players, Market Share and Ranking
    3.1 By Revenue of Hepatitis B Antiviral Drugs, Japan Market Share by Company, 2021-2026
    3.2 Japan Hepatitis B Antiviral Drugs Hepatitis B Antiviral Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
    4.1 Hepatitis B Antiviral Drugs Industry Chain
    4.2 Hepatitis B Antiviral Drugs Upstream Analysis
        4.2.1 Hepatitis B Antiviral Drugs Core Raw Materials
        4.2.2 Main Manufacturers of Hepatitis B Antiviral Drugs Core Raw Materials
    4.3 Midstream Analysis
    4.4 Downstream Analysis
    4.5 Hepatitis B Antiviral Drugs Production Mode
    4.6 Hepatitis B Antiviral Drugs Procurement Model
    4.7 Hepatitis B Antiviral Drugs Industry Sales Model and Sales Channels
        4.7.1 Hepatitis B Antiviral Drugs Sales Model
        4.7.2 Hepatitis B Antiviral Drugs Typical Distributors
5 Sights by Type
    5.1 Hepatitis B Antiviral Drugs Classification by Type
        5.1.1 Nucleos(t)ide Analogues
        5.1.2 Interferons
    5.2 by Type, Global Hepatitis B Antiviral Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032
    5.3 by Type, Global Hepatitis B Antiviral Drugs Consumption Value, 2021-2032
6 Sights by Application
    6.1 Hepatitis B Antiviral Drugs Segment by Application
        6.1.1 Hospital
        6.1.2 Clinic
        6.1.3 Others
    6.2 by Application, Global Hepatitis B Antiviral Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032
    6.3 by Application, Global Hepatitis B Antiviral Drugs Consumption Value, 2021-2032
7 Sales Sights by Region
    7.1 By Region, Global Hepatitis B Antiviral Drugs Consumption Value, 2021 VS 2025 VS 2032
    7.2 By Region, Global Hepatitis B Antiviral Drugs Consumption Value, 2021-2032
    7.3 North America
        7.3.1 North America Hepatitis B Antiviral Drugs Market Size & Forecasts, 2021-2032
        7.3.2 By Country, North America Hepatitis B Antiviral Drugs Market Size Market Share
    7.4 Europe
        7.4.1 Europe Hepatitis B Antiviral Drugs Market Size & Forecasts, 2021-2032
        7.4.2 By Country, Europe Hepatitis B Antiviral Drugs Market Size Market Share
    7.5 Asia Pacific
        7.5.1 Asia Pacific Hepatitis B Antiviral Drugs Market Size & Forecasts, 2021-2032
        7.5.2 By Country/Region, Asia Pacific Hepatitis B Antiviral Drugs Market Size Market Share
    7.6 South America
        7.6.1 South AmericaHepatitis B Antiviral Drugs Market Size & Forecasts, 2021-2032
        7.6.2 By Country, South America Hepatitis B Antiviral Drugs Market Size Market Share
    7.7 Middle East & Africa
8 Sales Sights by Country Level
    8.1 By Country, Global Hepatitis B Antiviral Drugs Market Size & CAGR, 2021 VS 2025 VS 2032
    8.2 By Country, Global Hepatitis B Antiviral Drugs Consumption Value, 2021-2032
    8.3 United States
        8.3.1 United States Hepatitis B Antiviral Drugs Market Size, 2021-2032
        8.3.2 by Type, United States Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
        8.3.3 by Application, United States Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
    8.4 Europe
        8.4.1 Europe Hepatitis B Antiviral Drugs Market Size, 2021-2032
        8.4.2 by Type, Europe Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
        8.4.3 by Application, Europe Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
    8.5 China
        8.5.1 China Hepatitis B Antiviral Drugs Market Size, 2021-2032
        8.5.2 by Type, China Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
        8.5.3 by Application, China Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
    8.6 Japan
        8.6.1 Japan Hepatitis B Antiviral Drugs Market Size, 2021-2032
        8.6.2 by Type, Japan Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
        8.6.3 by Application, Japan Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
    8.7 South Korea
        8.7.1 South Korea Hepatitis B Antiviral Drugs Market Size, 2021-2032
        8.7.2 by Type, South Korea Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
        8.7.3 by Application, South Korea Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
    8.8 Southeast Asia
        8.8.1 Southeast Asia Hepatitis B Antiviral Drugs Market Size, 2021-2032
        8.8.2 by Type, Southeast Asia Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
        8.8.3 by Application, Southeast Asia Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
    8.9 India
        8.9.1 India Hepatitis B Antiviral Drugs Market Size, 2021-2032
        8.9.2 by Type, India Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
        8.9.3 by Application, India Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
    8.10 Middle East & Africa
        8.10.1 Middle East & Africa Hepatitis B Antiviral Drugs Market Size, 2021-2032
        8.10.2 by Type, Middle East & Africa Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
        8.10.3 by Application, Middle East & Africa Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
9 Company Profile
    9.1 GSK
        9.1.1 GSK Company Information, Head Office, Market Area, and Industry Position
        9.1.2 GSK Company Profile and Main Business
        9.1.3 GSK Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.1.4 GSK Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.1.5 GSK Recent Developments
    9.2 Bristol Myers Squibb
        9.2.1 Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position
        9.2.2 Bristol Myers Squibb Company Profile and Main Business
        9.2.3 Bristol Myers Squibb Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.2.4 Bristol Myers Squibb Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.2.5 Bristol Myers Squibb Recent Developments
    9.3 Gilead Sciences
        9.3.1 Gilead Sciences Company Information, Head Office, Market Area, and Industry Position
        9.3.2 Gilead Sciences Company Profile and Main Business
        9.3.3 Gilead Sciences Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.3.4 Gilead Sciences Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.3.5 Gilead Sciences Recent Developments
    9.4 Novartis
        9.4.1 Novartis Company Information, Head Office, Market Area, and Industry Position
        9.4.2 Novartis Company Profile and Main Business
        9.4.3 Novartis Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.4.4 Novartis Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.4.5 Novartis Recent Developments
    9.5 Roche
        9.5.1 Roche Company Information, Head Office, Market Area, and Industry Position
        9.5.2 Roche Company Profile and Main Business
        9.5.3 Roche Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.5.4 Roche Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.5.5 Roche Recent Developments
    9.6 Merck
        9.6.1 Merck Company Information, Head Office, Market Area, and Industry Position
        9.6.2 Merck Company Profile and Main Business
        9.6.3 Merck Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.6.4 Merck Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.6.5 Merck Recent Developments
    9.7 Johnson & Johnson
        9.7.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
        9.7.2 Johnson & Johnson Company Profile and Main Business
        9.7.3 Johnson & Johnson Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.7.4 Johnson & Johnson Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.7.5 Johnson & Johnson Recent Developments
    9.8 Dawnrays Pharmaceutical
        9.8.1 Dawnrays Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
        9.8.2 Dawnrays Pharmaceutical Company Profile and Main Business
        9.8.3 Dawnrays Pharmaceutical Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.8.4 Dawnrays Pharmaceutical Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.8.5 Dawnrays Pharmaceutical Recent Developments
    9.9 Hansoh Pharmaceutical
        9.9.1 Hansoh Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
        9.9.2 Hansoh Pharmaceutical Company Profile and Main Business
        9.9.3 Hansoh Pharmaceutical Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.9.4 Hansoh Pharmaceutical Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.9.5 Hansoh Pharmaceutical Recent Developments
    9.10 Chia Tai-Tianqing Pharmaceutical
        9.10.1 Chia Tai-Tianqing Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
        9.10.2 Chia Tai-Tianqing Pharmaceutical Company Profile and Main Business
        9.10.3 Chia Tai-Tianqing Pharmaceutical Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.10.4 Chia Tai-Tianqing Pharmaceutical Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.10.5 Chia Tai-Tianqing Pharmaceutical Recent Developments
    9.11 Qilu pharmaceutical
        9.11.1 Qilu pharmaceutical Company Information, Head Office, Market Area, and Industry Position
        9.11.2 Qilu pharmaceutical Company Profile and Main Business
        9.11.3 Qilu pharmaceutical Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.11.4 Qilu pharmaceutical Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.11.5 Qilu pharmaceutical Recent Developments
    9.12 Fujian Cosunter Pharma
        9.12.1 Fujian Cosunter Pharma Company Information, Head Office, Market Area, and Industry Position
        9.12.2 Fujian Cosunter Pharma Company Profile and Main Business
        9.12.3 Fujian Cosunter Pharma Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.12.4 Fujian Cosunter Pharma Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.12.5 Fujian Cosunter Pharma Recent Developments
    9.13 Xiamen Amoytop Biotech
        9.13.1 Xiamen Amoytop Biotech Company Information, Head Office, Market Area, and Industry Position
        9.13.2 Xiamen Amoytop Biotech Company Profile and Main Business
        9.13.3 Xiamen Amoytop Biotech Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.13.4 Xiamen Amoytop Biotech Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.13.5 Xiamen Amoytop Biotech Recent Developments
    9.14 YaoPharma
        9.14.1 YaoPharma Company Information, Head Office, Market Area, and Industry Position
        9.14.2 YaoPharma Company Profile and Main Business
        9.14.3 YaoPharma Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.14.4 YaoPharma Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.14.5 YaoPharma Recent Developments
    9.15 Kelun Pharmaceutical
        9.15.1 Kelun Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
        9.15.2 Kelun Pharmaceutical Company Profile and Main Business
        9.15.3 Kelun Pharmaceutical Hepatitis B Antiviral Drugs Models, Specifications, and Application
        9.15.4 Kelun Pharmaceutical Hepatitis B Antiviral Drugs Revenue and Gross Margin, 2021-2026
        9.15.5 Kelun Pharmaceutical Recent Developments
10 Conclusion
11 Appendix
    11.1 Research Methodology
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Market Estimation Model
    11.4 Disclaimer
title

Table of Figures

List of Tables
 Table 1. Hepatitis B Antiviral Drugs Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million
 Table 2. Hepatitis B Antiviral Drugs Market Restraints
 Table 3. Hepatitis B Antiviral Drugs Market Trends
 Table 4. Hepatitis B Antiviral Drugs Industry Policy
 Table 5. Global Hepatitis B Antiviral Drugs Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 6. Global Hepatitis B Antiviral Drugs Revenue Share by Company, 2021-2026, Ranked by Data of 2025
 Table 7. Global Hepatitis B Antiviral Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
 Table 8. Global Hepatitis B Antiviral Drugs Mergers & Acquisitions, Expansion Plans
 Table 9. Global Hepatitis B Antiviral Drugs Major Companies Product Type
 Table 10. Head Office and Area Served of Key Players
 Table 11. Japan Hepatitis B Antiviral Drugs Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 12. Japan Hepatitis B Antiviral Drugs Revenue Market Share by Company, 2021-2026
 Table 13. Global Key Players of Hepatitis B Antiviral Drugs Upstream (Raw Materials)
 Table 14. Global Hepatitis B Antiviral Drugs Typical Customers
 Table 15. Hepatitis B Antiviral Drugs Typical Distributors
 Table 16. by Type, Global Hepatitis B Antiviral Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 17. by Application, Global Hepatitis B Antiviral Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 18. By Region, Global Hepatitis B Antiviral Drugs Consumption Value, 2021 VS 2025 VS 2032, US$ Million
 Table 19. By Region, Global Hepatitis B Antiviral Drugs Consumption Value, 2021-2032, US$ Million
 Table 20. By Country, Global Hepatitis B Antiviral Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 21. By Country, Global Hepatitis B Antiviral Drugs Consumption Value, 2021-2032, US$ Million
 Table 22. By Country, Global Hepatitis B Antiviral Drugs Consumption Value Market Share, 2021-2032
 Table 23. GSK Company Information, Head Office, Market Area, and Industry Position
 Table 24. GSK Company Profile and Main Business
 Table 25. GSK Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 26. GSK Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 27. GSK Recent Developments
 Table 28. Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position
 Table 29. Bristol Myers Squibb Company Profile and Main Business
 Table 30. Bristol Myers Squibb Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 31. Bristol Myers Squibb Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 32. Bristol Myers Squibb Recent Developments
 Table 33. Gilead Sciences Company Information, Head Office, Market Area, and Industry Position
 Table 34. Gilead Sciences Company Profile and Main Business
 Table 35. Gilead Sciences Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 36. Gilead Sciences Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 37. Gilead Sciences Recent Developments
 Table 38. Novartis Company Information, Head Office, Market Area, and Industry Position
 Table 39. Novartis Company Profile and Main Business
 Table 40. Novartis Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 41. Novartis Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 42. Novartis Recent Developments
 Table 43. Roche Company Information, Head Office, Market Area, and Industry Position
 Table 44. Roche Company Profile and Main Business
 Table 45. Roche Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 46. Roche Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 47. Roche Recent Developments
 Table 48. Merck Company Information, Head Office, Market Area, and Industry Position
 Table 49. Merck Company Profile and Main Business
 Table 50. Merck Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 51. Merck Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 52. Merck Recent Developments
 Table 53. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
 Table 54. Johnson & Johnson Company Profile and Main Business
 Table 55. Johnson & Johnson Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 56. Johnson & Johnson Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 57. Johnson & Johnson Recent Developments
 Table 58. Dawnrays Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
 Table 59. Dawnrays Pharmaceutical Company Profile and Main Business
 Table 60. Dawnrays Pharmaceutical Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 61. Dawnrays Pharmaceutical Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 62. Dawnrays Pharmaceutical Recent Developments
 Table 63. Hansoh Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
 Table 64. Hansoh Pharmaceutical Company Profile and Main Business
 Table 65. Hansoh Pharmaceutical Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 66. Hansoh Pharmaceutical Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 67. Hansoh Pharmaceutical Recent Developments
 Table 68. Chia Tai-Tianqing Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
 Table 69. Chia Tai-Tianqing Pharmaceutical Company Profile and Main Business
 Table 70. Chia Tai-Tianqing Pharmaceutical Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 71. Chia Tai-Tianqing Pharmaceutical Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 72. Chia Tai-Tianqing Pharmaceutical Recent Developments
 Table 73. Qilu pharmaceutical Company Information, Head Office, Market Area, and Industry Position
 Table 74. Qilu pharmaceutical Company Profile and Main Business
 Table 75. Qilu pharmaceutical Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 76. Qilu pharmaceutical Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 77. Qilu pharmaceutical Recent Developments
 Table 78. Fujian Cosunter Pharma Company Information, Head Office, Market Area, and Industry Position
 Table 79. Fujian Cosunter Pharma Company Profile and Main Business
 Table 80. Fujian Cosunter Pharma Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 81. Fujian Cosunter Pharma Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 82. Fujian Cosunter Pharma Recent Developments
 Table 83. Xiamen Amoytop Biotech Company Information, Head Office, Market Area, and Industry Position
 Table 84. Xiamen Amoytop Biotech Company Profile and Main Business
 Table 85. Xiamen Amoytop Biotech Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 86. Xiamen Amoytop Biotech Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 87. Xiamen Amoytop Biotech Recent Developments
 Table 88. YaoPharma Company Information, Head Office, Market Area, and Industry Position
 Table 89. YaoPharma Company Profile and Main Business
 Table 90. YaoPharma Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 91. YaoPharma Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 92. YaoPharma Recent Developments
 Table 93. Kelun Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
 Table 94. Kelun Pharmaceutical Company Profile and Main Business
 Table 95. Kelun Pharmaceutical Hepatitis B Antiviral Drugs Models, Specifications, and Application
 Table 96. Kelun Pharmaceutical Hepatitis B Antiviral Drugs Revenue and Gross Margin, US$ Million, 2021-2026
 Table 97. Kelun Pharmaceutical Recent Developments


List of Figures
 Figure 1. Hepatitis B Antiviral Drugs Picture
 Figure 2. Global Hepatitis B Antiviral Drugs Consumption Value, (US$ million) & (2021-2032)
 Figure 3. Japan Hepatitis B Antiviral Drugs Consumption Value, (US$ million) & (2021-2032)
 Figure 4. By Consumption Value, Japan Hepatitis B Antiviral Drugs Market Share of Global, 2021-2032
 Figure 5. Global Hepatitis B Antiviral Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025
 Figure 6. Japan Hepatitis B Antiviral Drugs Key Participants, Market Share, 2025
 Figure 7. Hepatitis B Antiviral Drugs Industry Chain
 Figure 8. Hepatitis B Antiviral Drugs Procurement Model
 Figure 9. Hepatitis B Antiviral Drugs Sales Model
 Figure 10. Hepatitis B Antiviral Drugs Sales Channels, Direct Sales, and Distribution
 Figure 11. Nucleos(t)ide Analogues
 Figure 12. Interferons
 Figure 13. by Type, Global Hepatitis B Antiviral Drugs Consumption Value, 2021-2032, US$ Million
 Figure 14. by Type, Global Hepatitis B Antiviral Drugs Consumption Value Market Share, 2021-2032
 Figure 15. Hospital
 Figure 16. Clinic
 Figure 17. Others
 Figure 18. by Application, Global Hepatitis B Antiviral Drugs Consumption Value, 2021-2032, US$ Million
 Figure 19. by Application, Global Hepatitis B Antiviral Drugs Revenue Market Share, 2021-2032
 Figure 20. By Region, Global Hepatitis B Antiviral Drugs Consumption Value Market Share, 2021-2032
 Figure 21. North America Hepatitis B Antiviral Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 22. By Country, North America Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025
 Figure 23. Europe Hepatitis B Antiviral Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 24. By Country, Europe Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025
 Figure 25. Asia Pacific Hepatitis B Antiviral Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 26. By Country/Region, Asia Pacific Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025
 Figure 27. South America Hepatitis B Antiviral Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 28. By Country, South America Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025
 Figure 29. Middle East & Africa Hepatitis B Antiviral Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 30. United States Hepatitis B Antiviral Drugs Consumption Value, 2021-2032, US$ Million
 Figure 31. by Type, United States Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 32. by Application, United States Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 33. Europe Hepatitis B Antiviral Drugs Consumption Value, 2021-2032, US$ Million
 Figure 34. by Type, Europe Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 35. by Application, Europe Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 36. China Hepatitis B Antiviral Drugs Consumption Value, 2021-2032, US$ Million
 Figure 37. by Type, China Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 38. by Application, China Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 39. Japan Hepatitis B Antiviral Drugs Consumption Value, 2021-2032, US$ Million
 Figure 40. by Type, Japan Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 41. by Application, Japan Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 42. South Korea Hepatitis B Antiviral Drugs Consumption Value, 2021-2032, US$ Million
 Figure 43. by Type, South Korea Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 44. by Application, South Korea Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 45. Southeast Asia Hepatitis B Antiviral Drugs Consumption Value, 2021-2032, US$ Million
 Figure 46. by Type, Southeast Asia Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 47. by Application, Southeast Asia Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 48. India Hepatitis B Antiviral Drugs Consumption Value, 2021-2032, US$ Million
 Figure 49. by Type, India Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 50. by Application, India Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 51. Middle East & Africa Hepatitis B Antiviral Drugs Consumption Value, 2021-2032, US$ Million
 Figure 52. by Type, Middle East & Africa Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 53. by Application, Middle East & Africa Hepatitis B Antiviral Drugs Consumption Value Market Share, 2025 VS 2032
 Figure 54. Research Methodology
 Figure 55. Breakdown of Primary Interviews
 Figure 56. Bottom-up Approaches
 Figure 57. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット
  • jiantou

    多言語（英語、日本語）のサンプル提供

  • jiantou

    プロフェッショナルな日本語翻訳を提供

  • jiantou

    請求書、クレジットカードでのお支払いが可能です

  • jiantou

    必要なチャプターやカスタマイズされたレポートの注文が可能

  • jiantou

    購入後、アナリストに直接連絡することができます

購入方法
shunxu

  • 必要な言語とバージョンのレポート選択

  • レポート要件と見積もり依頼

  • 電子メールによる注文

  • レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）

  • クレジットカード決済、オフライン振込に対応（後払い可）

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）
ご利用ガイド
利用規約よくあるご質問プライバシーポリシー支払い方法と購入ガイド
お電話でのお問い合わせ
email050-5840-2692 日本
email0081-50-5840-2692 グローバル
9:00-18:00 (土日・祝日を除く)
底部logo
Copyright 2016-2026 Global Reports著作権所有